Using irAOP for non-clinical safety evaluation of biotechnology-derived pharmaceuticals and ATMPs: a paradigm shift into a systematic and holistic framework
The chances and opportunities in modern biology inspired devising new therapeutics are mind blowing. The promises reach from successfully treating so-far incurable diseases like cancer and certain infections, to modulating and fine tuning the immune response to prolong the lifespan by inhibiting agi...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2024-12-01
|
| Schriftenreihe: | Journal of Immunotoxicology |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/1547691X.2024.2390920 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|